Vaccinex Shares Tumble 63% On Nasdaq Delisting

Dow Jones

2024/12/18

By Katherine Hamilton

Vaccinex shares dropped Tuesday after the company said it is being delisted from the Nasdaq capital market after falling short of the minimum stockholder equity required for listing.

The stock lost about two-thirds of its value on Tuesday. Shares are down 87% to $1.37 this year.

The biotechnology company, which specializes in treating neurodegenerative diseases, said Nasdaq gave notice on Monday it was delisting the company. Vaccinex has previously said it did not maintain the minimum $2.5 million in stockholders' equity required to be listed on the market.

Trading in Vaccinex's common stock will be suspended starting on Wednesday when the market opens, the company said.

After its delisting from Nasdaq, Vaccinex said it expects its stock will be on the OTC Markets Group under the symbol VCNX.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

December 17, 2024 11:55 ET (16:55 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492960184"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492960184\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492960184?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-18 00:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492960184","market":"sg","top_or_hot":-1,"title":"Vaccinex Shares Tumble 63% On Nasdaq Delisting","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Vaccinex shares dropped Tuesday after the company said it is being delisted from the Nasdaq capital market after falling short of the minimum stockholder equity required for listing. \n</p>\n<p>\n  The stock lost about two-thirds of its value on Tuesday. Shares are down 87% to $1.37 this year. \n</p>\n<p>\n  The biotechnology company, which specializes in treating neurodegenerative diseases, said Nasdaq gave notice on Monday it was delisting the company. Vaccinex has previously said it did not maintain the minimum $2.5 million in stockholders' equity required to be listed on the market. \n</p>\n<p>\n  Trading in Vaccinex's common stock will be suspended starting on Wednesday when the market opens, the company said. \n</p>\n<p>\n  After its delisting from Nasdaq, Vaccinex said it expects its stock will be on the OTC Markets Group under the symbol VCNX. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 17, 2024 11:55 ET (16:55 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccinex Shares Tumble 63% On Nasdaq Delisting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccinex Shares Tumble 63% On Nasdaq Delisting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-18 00:55</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre>\n \n</pre>\n<p>\n  Vaccinex shares dropped Tuesday after the company said it is being delisted from the Nasdaq capital market after falling short of the minimum stockholder equity required for listing. \n</p>\n<p>\n  The stock lost about two-thirds of its value on Tuesday. Shares are down 87% to $1.37 this year. \n</p>\n<p>\n  The biotechnology company, which specializes in treating neurodegenerative diseases, said Nasdaq gave notice on Monday it was delisting the company. Vaccinex has previously said it did not maintain the minimum $2.5 million in stockholders' equity required to be listed on the market. \n</p>\n<p>\n  Trading in Vaccinex's common stock will be suspended starting on Wednesday when the market opens, the company said. \n</p>\n<p>\n  After its delisting from Nasdaq, Vaccinex said it expects its stock will be on the OTC Markets Group under the symbol VCNX. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 17, 2024 11:55 ET (16:55 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BGHQF748.EUR","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2492960184","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492960184","pubTimestamp":1734454500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Vaccinex shares dropped Tuesday after the company said it is being delisted from the Nasdaq capital market after falling short of the minimum stockholder equity required for listing.The stock lost about two-thirds of its value on Tuesday. Shares are down 87% to $1.37 this year.The biotechnology company, which specializes in treating neurodegenerative diseases, said Nasdaq gave notice on Monday it was delisting the company. Vaccinex has previously said it did not maintain the minimum $2.5 million in stockholders' equity required to be listed on the market.Trading in Vaccinex's common stock will be suspended starting on Wednesday when the market opens, the company said.After its delisting from Nasdaq, Vaccinex said it expects its stock will be on the OTC Markets Group under the symbol VCNX.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC",".IXIC":"NASDAQ Composite","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4588":"碎股","BK4568":"美国抗疫概念","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4112":"金融交易所和数据","NDAQ":"纳斯达克OMX交易所","VCNX":"Vaccinex Inc.","BK4585":"ETF&股票定投概念","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4139":"生物科技"},"translate_title":"纳斯达克退市后Vaccinex股价暴跌63%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"NDAQ":1,"VCNX":0.9,"NQmain":1},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Vaccinex shares dropped Tuesday after the company said it is being delisted from the Nasdaq capital market after falling short of the minimum stockholder equity required for listing. \n\n\n  The stock lost about two-thirds of its value on Tuesday. Shares are down 87% to $1.37 this year. \n\n\n  The biotechnology company, which specializes in treating neurodegenerative diseases, said Nasdaq gave notice on Monday it was delisting the company. Vaccinex has previously said it did not maintain the minimum $2.5 million in stockholders' equity required to be listed on the market. \n\n\n  Trading in Vaccinex's common stock will be suspended starting on Wednesday when the market opens, the company said. \n\n\n  After its delisting from Nasdaq, Vaccinex said it expects its stock will be on the OTC Markets Group under the symbol VCNX. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2024 11:55 ET (16:55 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}